New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 30, 2014
08:42 EDTMNKDMannKind Afrezza facing 'daunting' commercial hurdles, says JPMorgan
JPMorgan believes Afrezza's label with a Black Box warning and requirement for pulmonary testing show the FDA's concerns around pulmonary toxicity. The firm believes the drug faces "daunting" commercial hurdles and it keeps a Neutral rating on the stock with a $6 price target.
News For MNKD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 31, 2015
05:36 EDTMNKDStocks with implied volatility movement; MNKD ABT
Subscribe for More Information
August 27, 2015
05:54 EDTMNKDStocks with implied volatility above IV index mean; MNKD AMBA
Subscribe for More Information
August 26, 2015
05:52 EDTMNKDStocks with implied volatility movement; TSM MNKD
Subscribe for More Information
August 20, 2015
09:47 EDTMNKDMannKind failed to settle loan by deadline, TheStreet's Feuerstein says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use